PharmaBoardroom

Interview with Dieter Torheiden, Managing Director, Solvay…

How will the PBS reforms affect Solvay? The easy answer is: heavily. Fortunately, Solvay’s leading product which is still under patent will not…

Interview with Troy Guthrie, Managing Director, Stiefel…

What impact will the recent PBS reforms have on Stiefel’s operations in Australia? Stiefel has no products on the PBS at the moment, and although…

Interview with Hans-Dieter Hausner, Senior Bayer Representative,…

Many MNCs are having pipeline concerns in the “new era” of post-blockbuster drug development. How is Bayer positioned in this respect?…

Interview with Suzanne Hill, Chair, Pharmaceutical Benefits…

To begin, would you please give a brief introduction to the PBAC? The PBAC is a statutory committee of government first developed in Australia in the…

Interview with Senator Kim Carr, Minister, Government of…

The Ministry for Innovation, Industry, Science and Research was created in December 2007 with the election of the Labor government. To begin, would…

Interview with Emad Mohareb, Managing Director, Pierre Fabre…

Would you please introduce Pierre Fabre to our readers? Pierre Fabre Medicament Australia Pty Limited was established in Australia in late 2001, and…

Interview with Luis Ricciardulli, Regional Manager, Nycomed Latin…

The executive management of Nycomed said in an interview that ‘the tremendous growth of the pharmaceutical industry will not occur in either Europe…

Interview with José Tombazzi, President, Denver Farma

Could you give us an overview of the generics sector in Argentina as it stands at the moment? The generics market in Argentina was started immediately…

Interview with Helen Allars and John Edington, Managing Director…

The Australian pharmaceutical sector has seen recent innovations through PBS reform and various working groups shaping the future of the industry. Can…